Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane's Effect on Neurocognition Study
NCT06044740Phase 1Completed
- Start
- Jan 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of sevoflurane. Primary endpoints: Functional magnetic resonance imaging activation in response to experimental tasks and Functional connectivity. Started Jan 2024; status: completed.
02
Drugs
sevoflurane
Beyond the preview
Go deeper on NCT06044740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06044740.